Holen Sie sich die Stockscreener-App
162.96
2.68%
4.26
Vorhandelsmarkt:
163.41
0.45
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc. stock (US4523271090): shares track Nasdaq ahead of next catalysts - AD HOC NEWS
Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance
Illumina Inc. stock (US4523271090): insider share sale and new MRD kit draw investor focus - AD HOC NEWS
Illumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
lllumina Beats Rival’s DNA-Sequencing Tool Monopolization Claims - Bloomberg Law News
Illumina, Inc. Hits Day High with Strong 5.68% Intraday Surge - Markets Mojo
Illumina Inc. stock (US4523271090): shares near 12-month high after new automation launch - AD HOC NEWS
Illumina and SPT Labtech on fire with new collaboration - Business Weekly
Illumina Inc stock (US4523271090): New MRD research launch and fresh 52-week high draw focus to valu - AD HOC NEWS
Illumina stock hits 52-week high at 155.6 USD By Investing.com - Investing.com Nigeria
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research - Illumina
Illumina's new fireflyGO robot targets faster cancer lab workflows - Stock Titan
Illumina, Inc. Introduces Distributed Whole-Genome Sequencing Solution For Highly Sensitive MRD Research - marketscreener.com
Illumina stock hits 52-week high at 155.6 USD - Investing.com
Illumina launches whole-genome sequencing kit for cancer research - Investing.com
Illumina launches whole-genome sequencing kit for cancer research By Investing.com - Investing.com UK
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research - PR Newswire
Is Illumina Inc (ILMN) Overvalued After 3.4% Rally? GF Value Say - GuruFocus
Illumina, Inc. Files Form 8-K Announcing Annual Meeting Results and Company Information (May 2026) - Minichart
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Action challenging Commission’s jurisdiction over Grail’s acquisition of Illumina, published in OJ - EU Law Live
Illumina Multiomics Summit India highlights potential of integrated omics - BioSpectrum India
Illumina Inc. stock (US4523271090): Focus shifts to core sequencing business after divesting GRAIL - AD HOC NEWS
How Adding Diagnostics Veteran David King To The Board At Illumina (ILMN) Has Changed Its Investment Story - simplywall.st
Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential with a 33.82% ROE - DirectorsTalk Interviews
ILMN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Illumina stock (US4523271090): institutional buying meets cautious analyst outlook - AD HOC NEWS
Illumina Summit Highlights Multi-Omics Potential in India - Deccan Chronicle
Illumina (NASDAQ: ILMN) director Susan Siegel receives 2,072-share RSU grant - Stock Titan
Illumina (ILMN) awards 2,072 restricted stock units to director - Stock Titan
Illumina (ILMN) director Scott B. Ullem receives 2,072-share RSU award - Stock Titan
Illumina (ILMN) director Philip Schiller receives 2,072-share restricted stock grant - Stock Titan
Illumina (ILMN) director Anna Richo granted 2,072 restricted stock units as equity pay - Stock Titan
Illumina (ILMN) director Keith Meister granted 2,072 RSUs and updates holdings - Stock Titan
Illumina (ILMN) director Scott Gottlieb receives 2,072-share RSU grant - Stock Titan
Illumina (ILMN) director David P. King submits initial Form 3 - Stock Titan
Illumina’s SWOT analysis: stock faces visibility concerns despite growth By Investing.com - Investing.com Canada
Illumina’s SWOT analysis: stock faces visibility concerns despite growth - Investing.com
Illumina adds former Labcorp CEO to board of directors - Investing.com UK
Understanding Momentum Shifts in (ILMN) - Stock Traders Daily
Illumina adds former Labcorp CEO to board of directors By Investing.com - Investing.com South Africa
David P. King elected to Illumina's Board of Directors - Illumina
ILMN: All proposals were preliminarily approved, with no questions raised during the Q&A session - TradingView
DNA Methylation Sequencing Market to Reach USD 5.49 Billion - openPR.com
NGS-Based RNA Sequencing Market to Reach USD 15.0 Billion by 2033 - openPR.com
Illumina stock (US4523271090): corporate responsibility push after return to growth - AD HOC NEWS
Illumina stock (US4523271090): Corporate Responsibility Report highlights genomics growth drivers - AD HOC NEWS
3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Yahoo Finance
Is This the Right Time to Retain ILMN Stock in Your Portfolio? - Yahoo Finance
Illumina stock (US4523271090): new responsibility report highlights growth drivers in genomics - AD HOC NEWS
Earnings Beat, Buyback, China Signals Might Change The Case For Investing In Illumina (ILMN) - Yahoo Finance
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR Newswire
SomaLogic Inc stock (US82489T1043): Illumina takeover reshapes proteomics story - AD HOC NEWS
Illumina Releases 2025 Corporate Responsibility Report, Expanding Access to Genomics and Accelerating Global Impact - 富途牛牛
Illumina stock (US4523271090): analysts see limited upside after volatile Nasdaq recovery - AD HOC NEWS
Illumina price tries to vent off overbought saturationForecast today18-05-2026 - Economies.com
NXP, Illumina, StoneX Group: Momentum Stocks Analysis (Buy & Sell)May 2026News and Statistics - IndexBox
Illumina stock (US4523271090): analysts see limited upside after recent volatility - AD HOC NEWS
Illumina stock (US4523271090): analysts see limited upside after volatile trading - AD HOC NEWS
Illumina Inc stock (US4523271090): spin-off progress and earnings keep investors alert - AD HOC NEWS
Illumina, Inc. Trade Ideas — EUROTLX:4ILMN - TradingView
1.47%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):